Global Information
회사소개 | 문의 | 위시리스트

당화알부민 시장 : 규모, 점유율, 동향, 예측(-2026년)

Glycated Albumin Market - Size, Share, Trends, and Forecast to 2026

리서치사 Coherent Market Insights
발행일 2018년 07월 상품 코드 785769
페이지 정보 영문
가격
US $ 4,500 ₩ 5,524,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,593,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,277,000 PPT Turned PDF (Enterprise User License)


당화알부민 시장 : 규모, 점유율, 동향, 예측(-2026년) Glycated Albumin Market - Size, Share, Trends, and Forecast to 2026
발행일 : 2018년 07월 페이지 정보 : 영문

당화알부민은 글루코오스와 결합하는 알부민을 가리킵니다. 알부민은 혈액이나 체액에 존재하며, 세포 형상을 유지하고 호르몬, 영양, 약물을 운반하는 기능을 하고 있습니다. 당화알부민은 당뇨병의 검출 및 관리용 신규 바이오마커로 평가되고 있습니다. 또한 과거 수십년간 당뇨병의 혈당치 모니터링에서 중요성이 높아졌습니다.

세계의 당화알부민(Glycated Albumin) 시장을 조사했으며, 시장 개요, 제품 종류·용도·최종사용자·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 가정

  • 조사 목적
  • 가정
  • 약어

제2장 시장 범위

  • 보고서 개요
  • 시장 정의와 범위
  • 주요 요약
  • 시장 정보 : 제품 종류별
  • 시장 정보 : 용도별
  • 시장 정보 : 최종사용자별
  • 시장 정보 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회
  • 영향 분석
  • 제품 발매
  • 당화알부민의 중요성
  • 규제 시나리오
  • PEST 분석
  • Porter's Five Forces 분석

제4장 세계의 당화알부민 시장 : 제품 종류별

  • 서론
  • 시장 점유율 분석
  • 전년대비 성장률
  • 부문 동향
  • 사람 당화알부민
  • 동물 당화알부민

제5장 세계의 당화알부민 시장 : 용도별

  • 서론
  • 시장 점유율
  • 성장 분석
  • 부문 동향
  • 진단
  • 전당뇨병(Prediabetes)
    • 1형 당뇨병
    • 2형 당뇨병
  • 연구

제6장 세계의 당화알부민 시장 : 최종사용자별

  • 서론
  • 시장 점유율
  • 성장 분석
  • 부문 동향
  • 병원/진료소
  • 진단 센터
  • 연구기관

제7장 세계의 당화알부민 시장 : 지역별

  • 서론
  • 시장 점유율 분석
  • 전년대비 성장률
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 프랑스
    • 스페인
    • 러시아
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • ASEAN 국가
    • 호주
    • 한국
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타
  • 아프리카
    • 중앙아프리카
    • 남아프리카
    • 북아프리카
  • 중동
    • 걸프협력회의(GCC)
    • 이스라엘
    • 기타

제8장 경쟁 상황

  • 히트맵 해석
  • 기업 개요
    • Asahi Kasei Pharma Corporation
    • Lifespan Biosciences
    • Biomatik Corporation
    • Abbexa Ltd
    • G Bioscience
    • DRG International, Inc.
    • Amsbio LLC
    • Signalway Antibody LLC
    • United States Biological
    • Diazyme Laboratories
    • Abnova Corporation
    • Maccura Biotechnology Co. Ltd.
    • Exocell Inc.
    • Bior : Byt Ltd.
    • Epinex Diagnostics Inc.

제9장 부록

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights 소개
KSM 19.02.28

Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been described as novel biomarkers for the detection and management of diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus over the past few decades.

Market Dynamics

Increasing approval of novel glycated albumin products by key players in the market is expected to drive global glycated albumin kits/assays market growth in the near future. For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Japan-based Asahi Kasei Pharma Corporation for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L).

Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin products, which can be used for the diagnosis/ detection of different types of diabetes such as type 1, and type 2 diabetes. For instance, according to the data published by the American Diabetes Associations in 2015, diabetes is the 7th leading cause of death in the U.S., where around 30.3 million people in the U.S. are suffering from diabetes. Among these, around 193,000 people in the U.S. below the age of 20 are suffering from diabetes.

Key features of the study:

This report provides in-depth analysis of glycated albumin market and provides market size (US$ Million) and cumulative annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global glycated albumin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global glycated albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the glycated albumin market

Detailed Segmentation:

  • Global Glycated Albumin Market, By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • Global Glycated Albumin Market, By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • Global Glycated Albumin Market, By End User:
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • Global Glycated Albumin Market, By Geography:
  • North America
  • By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • By End User
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • By End User
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • By End User
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • By End User
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • By End User
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type :
  • Human Glycated Albumin
  • Animal Glycated Albumin
  • By Application:
  • Diagnosis
  • Prediabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Research
  • By End User
  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Asahi Kasei Pharma Corporation *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Lifespan Biosciences
  • Biomatik Corporation
  • Abbexa Ltd.
  • G Biosciences
  • DRG International, Inc.
  • Amsbio LLC
  • Signalway Antibody LLC
  • United States Biological
  • Diazyme Laboratories
  • Abnova Corporation
  • Maccura Biotechnology Co. Ltd.
  • Exocell Inc.
  • Biorbyt Ltd.
  • Epinex Diagnostics Inc.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Product Launch
    • Importance of Glycated Albumin
    • Regulatory Scenario
    • PEST Analysis
    • Porter's Five Forces Analysis

4. Global Glycated Albumin Market, By Product Type, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Human Glycated Albumin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Segment Trends
    • Animal Glycated Albumin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Glycated Albumin Market, By Application, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Segment Trends
    • Prediabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Glycated Albumin Market, By End User, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017-2026
    • Segment Trends
    • Hospitals/Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Glycated Albumin Market, By Region, 2016 - 2026 (US$ Mn)

    • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
    • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
    • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2026 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

8. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Asahi Kasei Pharma Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Lifespan Biosciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Biomatik Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abbexa Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • G Biosciences
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • DRG International, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Amsbio LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Signalway Antibody LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • United States Biological
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Diazyme Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Abnova Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Maccura Biotechnology Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Exocell Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Biorbyt Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Epinex Diagnostics Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top
전화 문의
F A Q